nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP2C8—Fluorouracil—head and neck cancer	0.174	0.42	CbGbCtD
Trimethadione—CYP2C9—Fluorouracil—head and neck cancer	0.122	0.293	CbGbCtD
Trimethadione—CYP3A4—Vinblastine—head and neck cancer	0.0655	0.158	CbGbCtD
Trimethadione—CYP3A4—Docetaxel—head and neck cancer	0.054	0.13	CbGbCtD
Trimethadione—Distress—Hydroxyurea—head and neck cancer	0.0449	0.0813	CcSEcCtD
Trimethadione—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.0335	0.0606	CcSEcCtD
Trimethadione—Emotional distress—Hydroxyurea—head and neck cancer	0.0293	0.0531	CcSEcCtD
Trimethadione—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.0225	0.0408	CcSEcCtD
Trimethadione—Emotional distress—Fluorouracil—head and neck cancer	0.0211	0.0382	CcSEcCtD
Trimethadione—Lupus erythematosus—Docetaxel—head and neck cancer	0.0174	0.0315	CcSEcCtD
Trimethadione—Photophobia—Vinblastine—head and neck cancer	0.0128	0.0232	CcSEcCtD
Trimethadione—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.0117	0.0212	CcSEcCtD
Trimethadione—Photophobia—Fluorouracil—head and neck cancer	0.00843	0.0153	CcSEcCtD
Trimethadione—Pancytopenia—Vinblastine—head and neck cancer	0.00815	0.0148	CcSEcCtD
Trimethadione—Pancytopenia—Hydroxyurea—head and neck cancer	0.00743	0.0135	CcSEcCtD
Trimethadione—Neutropenia—Hydroxyurea—head and neck cancer	0.00732	0.0132	CcSEcCtD
Trimethadione—Agranulocytosis—Vinblastine—head and neck cancer	0.00714	0.0129	CcSEcCtD
Trimethadione—Drowsiness—Hydroxyurea—head and neck cancer	0.00698	0.0126	CcSEcCtD
Trimethadione—Haemoglobin—Vinblastine—head and neck cancer	0.0069	0.0125	CcSEcCtD
Trimethadione—Haemorrhage—Vinblastine—head and neck cancer	0.00687	0.0124	CcSEcCtD
Trimethadione—Haemoglobin—Hydroxyurea—head and neck cancer	0.0063	0.0114	CcSEcCtD
Trimethadione—Haemorrhage—Hydroxyurea—head and neck cancer	0.00626	0.0113	CcSEcCtD
Trimethadione—Irritability—Fluorouracil—head and neck cancer	0.00622	0.0113	CcSEcCtD
Trimethadione—Alopecia—Vinblastine—head and neck cancer	0.00607	0.011	CcSEcCtD
Trimethadione—Eosinophilia—Fluorouracil—head and neck cancer	0.00558	0.0101	CcSEcCtD
Trimethadione—Ill-defined disorder—Vinblastine—head and neck cancer	0.00555	0.01	CcSEcCtD
Trimethadione—Alopecia—Hydroxyurea—head and neck cancer	0.00554	0.01	CcSEcCtD
Trimethadione—Malaise—Vinblastine—head and neck cancer	0.00539	0.00976	CcSEcCtD
Trimethadione—Vertigo—Vinblastine—head and neck cancer	0.00537	0.00972	CcSEcCtD
Trimethadione—Leukopenia—Vinblastine—head and neck cancer	0.00535	0.00969	CcSEcCtD
Trimethadione—Pancytopenia—Fluorouracil—head and neck cancer	0.00535	0.00968	CcSEcCtD
Trimethadione—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00506	0.00916	CcSEcCtD
Trimethadione—Discomfort—Vinblastine—head and neck cancer	0.00503	0.0091	CcSEcCtD
Trimethadione—Malaise—Hydroxyurea—head and neck cancer	0.00492	0.0089	CcSEcCtD
Trimethadione—Leukopenia—Hydroxyurea—head and neck cancer	0.00488	0.00883	CcSEcCtD
Trimethadione—Thrombocytopenia—Vinblastine—head and neck cancer	0.00478	0.00865	CcSEcCtD
Trimethadione—Epistaxis—Fluorouracil—head and neck cancer	0.00474	0.00857	CcSEcCtD
Trimethadione—Agranulocytosis—Fluorouracil—head and neck cancer	0.00469	0.00848	CcSEcCtD
Trimethadione—Anorexia—Vinblastine—head and neck cancer	0.00465	0.00842	CcSEcCtD
Trimethadione—Discomfort—Hydroxyurea—head and neck cancer	0.00459	0.0083	CcSEcCtD
Trimethadione—Haemoglobin—Fluorouracil—head and neck cancer	0.00453	0.0082	CcSEcCtD
Trimethadione—Haemorrhage—Fluorouracil—head and neck cancer	0.00451	0.00816	CcSEcCtD
Trimethadione—Paraesthesia—Vinblastine—head and neck cancer	0.00438	0.00793	CcSEcCtD
Trimethadione—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00436	0.00789	CcSEcCtD
Trimethadione—Anorexia—Hydroxyurea—head and neck cancer	0.00424	0.00768	CcSEcCtD
Trimethadione—Decreased appetite—Vinblastine—head and neck cancer	0.00424	0.00768	CcSEcCtD
Trimethadione—Feeling abnormal—Vinblastine—head and neck cancer	0.00402	0.00728	CcSEcCtD
Trimethadione—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00399	0.00722	CcSEcCtD
Trimethadione—Alopecia—Fluorouracil—head and neck cancer	0.00398	0.00721	CcSEcCtD
Trimethadione—Somnolence—Hydroxyurea—head and neck cancer	0.00396	0.00716	CcSEcCtD
Trimethadione—Decreased appetite—Hydroxyurea—head and neck cancer	0.00387	0.007	CcSEcCtD
Trimethadione—Pancytopenia—Docetaxel—head and neck cancer	0.00386	0.00699	CcSEcCtD
Trimethadione—Abdominal pain—Vinblastine—head and neck cancer	0.00386	0.00698	CcSEcCtD
Trimethadione—Fatigue—Hydroxyurea—head and neck cancer	0.00384	0.00694	CcSEcCtD
Trimethadione—Neutropenia—Docetaxel—head and neck cancer	0.0038	0.00688	CcSEcCtD
Trimethadione—Weight decreased—Docetaxel—head and neck cancer	0.00368	0.00666	CcSEcCtD
Trimethadione—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00367	0.00664	CcSEcCtD
Trimethadione—Leukopenia—Fluorouracil—head and neck cancer	0.00351	0.00636	CcSEcCtD
Trimethadione—Asthenia—Vinblastine—head and neck cancer	0.0035	0.00634	CcSEcCtD
Trimethadione—Epistaxis—Docetaxel—head and neck cancer	0.00342	0.00619	CcSEcCtD
Trimethadione—Agranulocytosis—Docetaxel—head and neck cancer	0.00338	0.00612	CcSEcCtD
Trimethadione—Discomfort—Fluorouracil—head and neck cancer	0.0033	0.00598	CcSEcCtD
Trimethadione—Haemoglobin—Docetaxel—head and neck cancer	0.00327	0.00592	CcSEcCtD
Trimethadione—Haemorrhage—Docetaxel—head and neck cancer	0.00325	0.00589	CcSEcCtD
Trimethadione—Hepatitis—Docetaxel—head and neck cancer	0.00325	0.00589	CcSEcCtD
Trimethadione—Asthenia—Hydroxyurea—head and neck cancer	0.00319	0.00578	CcSEcCtD
Trimethadione—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00314	0.00568	CcSEcCtD
Trimethadione—Vomiting—Vinblastine—head and neck cancer	0.0031	0.00562	CcSEcCtD
Trimethadione—Erythema multiforme—Docetaxel—head and neck cancer	0.00308	0.00557	CcSEcCtD
Trimethadione—Headache—Vinblastine—head and neck cancer	0.00306	0.00553	CcSEcCtD
Trimethadione—Anorexia—Fluorouracil—head and neck cancer	0.00305	0.00553	CcSEcCtD
Trimethadione—Nausea—Vinblastine—head and neck cancer	0.0029	0.00525	CcSEcCtD
Trimethadione—Insomnia—Fluorouracil—head and neck cancer	0.0029	0.00524	CcSEcCtD
Trimethadione—Paraesthesia—Fluorouracil—head and neck cancer	0.00288	0.00521	CcSEcCtD
Trimethadione—Alopecia—Docetaxel—head and neck cancer	0.00288	0.00521	CcSEcCtD
Trimethadione—Somnolence—Fluorouracil—head and neck cancer	0.00285	0.00515	CcSEcCtD
Trimethadione—Vomiting—Hydroxyurea—head and neck cancer	0.00283	0.00512	CcSEcCtD
Trimethadione—Rash—Hydroxyurea—head and neck cancer	0.00281	0.00508	CcSEcCtD
Trimethadione—Dermatitis—Hydroxyurea—head and neck cancer	0.0028	0.00507	CcSEcCtD
Trimethadione—Headache—Hydroxyurea—head and neck cancer	0.00279	0.00505	CcSEcCtD
Trimethadione—Decreased appetite—Fluorouracil—head and neck cancer	0.00278	0.00504	CcSEcCtD
Trimethadione—Nausea—Hydroxyurea—head and neck cancer	0.00264	0.00478	CcSEcCtD
Trimethadione—Feeling abnormal—Fluorouracil—head and neck cancer	0.00264	0.00478	CcSEcCtD
Trimethadione—Leukopenia—Docetaxel—head and neck cancer	0.00254	0.00459	CcSEcCtD
Trimethadione—Pruritus—Fluorouracil—head and neck cancer	0.00227	0.0041	CcSEcCtD
Trimethadione—Thrombocytopenia—Docetaxel—head and neck cancer	0.00226	0.0041	CcSEcCtD
Trimethadione—Anorexia—Docetaxel—head and neck cancer	0.0022	0.00399	CcSEcCtD
Trimethadione—Insomnia—Docetaxel—head and neck cancer	0.00209	0.00379	CcSEcCtD
Trimethadione—Paraesthesia—Docetaxel—head and neck cancer	0.00208	0.00376	CcSEcCtD
Trimethadione—Somnolence—Docetaxel—head and neck cancer	0.00206	0.00372	CcSEcCtD
Trimethadione—Vomiting—Fluorouracil—head and neck cancer	0.00204	0.00369	CcSEcCtD
Trimethadione—Rash—Fluorouracil—head and neck cancer	0.00202	0.00366	CcSEcCtD
Trimethadione—Dermatitis—Fluorouracil—head and neck cancer	0.00202	0.00365	CcSEcCtD
Trimethadione—Decreased appetite—Docetaxel—head and neck cancer	0.00201	0.00364	CcSEcCtD
Trimethadione—Headache—Fluorouracil—head and neck cancer	0.00201	0.00363	CcSEcCtD
Trimethadione—Fatigue—Docetaxel—head and neck cancer	0.00199	0.00361	CcSEcCtD
Trimethadione—Feeling abnormal—Docetaxel—head and neck cancer	0.00191	0.00345	CcSEcCtD
Trimethadione—Nausea—Fluorouracil—head and neck cancer	0.0019	0.00344	CcSEcCtD
Trimethadione—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00189	0.00342	CcSEcCtD
Trimethadione—Abdominal pain—Docetaxel—head and neck cancer	0.00183	0.00331	CcSEcCtD
Trimethadione—Asthenia—Docetaxel—head and neck cancer	0.00166	0.003	CcSEcCtD
Trimethadione—Pruritus—Docetaxel—head and neck cancer	0.00164	0.00296	CcSEcCtD
Trimethadione—Vomiting—Docetaxel—head and neck cancer	0.00147	0.00266	CcSEcCtD
Trimethadione—Rash—Docetaxel—head and neck cancer	0.00146	0.00264	CcSEcCtD
Trimethadione—Dermatitis—Docetaxel—head and neck cancer	0.00146	0.00264	CcSEcCtD
Trimethadione—Headache—Docetaxel—head and neck cancer	0.00145	0.00262	CcSEcCtD
Trimethadione—Nausea—Docetaxel—head and neck cancer	0.00137	0.00249	CcSEcCtD
Trimethadione—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00119	0.0369	CbGpPWpGaD
Trimethadione—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00108	0.0336	CbGpPWpGaD
Trimethadione—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00106	0.0329	CbGpPWpGaD
Trimethadione—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000965	0.03	CbGpPWpGaD
Trimethadione—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000963	0.03	CbGpPWpGaD
Trimethadione—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000878	0.0273	CbGpPWpGaD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000842	0.0262	CbGpPWpGaD
Trimethadione—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000788	0.0245	CbGpPWpGaD
Trimethadione—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000747	0.0232	CbGpPWpGaD
Trimethadione—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.000698	0.0217	CbGpPWpGaD
Trimethadione—CYP2E1—Xenobiotics—CYP1A1—head and neck cancer	0.000659	0.0205	CbGpPWpGaD
Trimethadione—CYP2E1—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000634	0.0197	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.000603	0.0187	CbGpPWpGaD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000592	0.0184	CbGpPWpGaD
Trimethadione—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000579	0.018	CbGpPWpGaD
Trimethadione—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.00057	0.0177	CbGpPWpGaD
Trimethadione—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000548	0.017	CbGpPWpGaD
Trimethadione—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000509	0.0158	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—CEBPA—head and neck cancer	0.000489	0.0152	CbGpPWpGaD
Trimethadione—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000489	0.0152	CbGpPWpGaD
Trimethadione—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000464	0.0144	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.000449	0.014	CbGpPWpGaD
Trimethadione—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000446	0.0139	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	0.000422	0.0131	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	0.000401	0.0125	CbGpPWpGaD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000391	0.0122	CbGpPWpGaD
Trimethadione—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000378	0.0118	CbGpPWpGaD
Trimethadione—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000366	0.0114	CbGpPWpGaD
Trimethadione—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000351	0.0109	CbGpPWpGaD
Trimethadione—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000339	0.0105	CbGpPWpGaD
Trimethadione—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000333	0.0103	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	0.000322	0.01	CbGpPWpGaD
Trimethadione—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000306	0.00951	CbGpPWpGaD
Trimethadione—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000294	0.00915	CbGpPWpGaD
Trimethadione—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000276	0.0086	CbGpPWpGaD
Trimethadione—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000274	0.00851	CbGpPWpGaD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000274	0.00851	CbGpPWpGaD
Trimethadione—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00027	0.0084	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000252	0.00783	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.000248	0.00772	CbGpPWpGaD
Trimethadione—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000247	0.00768	CbGpPWpGaD
Trimethadione—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000244	0.0076	CbGpPWpGaD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000237	0.00736	CbGpPWpGaD
Trimethadione—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000233	0.00726	CbGpPWpGaD
Trimethadione—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000225	0.007	CbGpPWpGaD
Trimethadione—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000223	0.00693	CbGpPWpGaD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000222	0.0069	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000218	0.00677	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000215	0.00668	CbGpPWpGaD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000211	0.00657	CbGpPWpGaD
Trimethadione—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000208	0.00648	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000194	0.00604	CbGpPWpGaD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000193	0.00599	CbGpPWpGaD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000192	0.00597	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000192	0.00596	CbGpPWpGaD
Trimethadione—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00019	0.00591	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000177	0.00551	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000175	0.00543	CbGpPWpGaD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000171	0.00533	CbGpPWpGaD
Trimethadione—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000163	0.00506	CbGpPWpGaD
Trimethadione—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000157	0.00489	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—NOTCH1—head and neck cancer	0.000156	0.00486	CbGpPWpGaD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000156	0.00486	CbGpPWpGaD
Trimethadione—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000151	0.00469	CbGpPWpGaD
Trimethadione—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000145	0.00452	CbGpPWpGaD
Trimethadione—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000132	0.00412	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—VEGFA—head and neck cancer	0.000128	0.00398	CbGpPWpGaD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000127	0.00395	CbGpPWpGaD
Trimethadione—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000125	0.0039	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000124	0.00387	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000123	0.00381	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MAPK3—head and neck cancer	0.000121	0.00376	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000118	0.00367	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000117	0.00363	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000116	0.00362	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000115	0.00358	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MAPK1—head and neck cancer	0.000115	0.00358	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—EGFR—head and neck cancer	0.000115	0.00358	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000107	0.00334	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000106	0.0033	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—UROD—head and neck cancer	0.000104	0.00322	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000103	0.0032	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000102	0.00317	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.0001	0.00313	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	9.59e-05	0.00298	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	9.46e-05	0.00294	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—HRAS—head and neck cancer	9.24e-05	0.00288	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—VEGFA—head and neck cancer	9.13e-05	0.00284	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	9.09e-05	0.00283	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—STAT3—head and neck cancer	9.04e-05	0.00281	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	8.97e-05	0.00279	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—UROD—head and neck cancer	8.96e-05	0.00279	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	8.75e-05	0.00272	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MAPK3—head and neck cancer	8.64e-05	0.00269	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	8.63e-05	0.00268	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	8.29e-05	0.00258	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MAPK1—head and neck cancer	8.22e-05	0.00256	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—EGFR—head and neck cancer	8.22e-05	0.00256	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	8.18e-05	0.00254	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—UROD—head and neck cancer	8e-05	0.00249	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—UROD—head and neck cancer	7.29e-05	0.00227	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.95e-05	0.00216	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—HRAS—head and neck cancer	6.6e-05	0.00205	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.21e-05	0.00193	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—AKT1—head and neck cancer	5.82e-05	0.00181	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.77e-05	0.00179	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.69e-05	0.00177	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.66e-05	0.00176	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.47e-05	0.0017	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.39e-05	0.00168	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—UROD—head and neck cancer	4.81e-05	0.0015	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—NAT2—head and neck cancer	4.3e-05	0.00134	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.95e-05	0.00123	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.91e-05	0.00122	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—DPYD—head and neck cancer	3.77e-05	0.00117	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—NAT2—head and neck cancer	3.72e-05	0.00116	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—YAP1—head and neck cancer	3.58e-05	0.00111	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.53e-05	0.0011	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.49e-05	0.00109	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—NAT2—head and neck cancer	3.32e-05	0.00103	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—DPYD—head and neck cancer	3.26e-05	0.00101	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.22e-05	0.001	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.18e-05	0.00099	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—YAP1—head and neck cancer	3.1e-05	0.000963	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—NAT2—head and neck cancer	3.03e-05	0.000942	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—DPYD—head and neck cancer	2.91e-05	0.000906	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—YAP1—head and neck cancer	2.76e-05	0.00086	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—DPYD—head and neck cancer	2.66e-05	0.000826	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—YAP1—head and neck cancer	2.52e-05	0.000784	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.33e-05	0.000724	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—TYMS—head and neck cancer	2.15e-05	0.000669	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTM1—head and neck cancer	2.13e-05	0.000661	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.08e-05	0.000646	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GPX1—head and neck cancer	2.04e-05	0.000633	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.03e-05	0.000631	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP1A1—head and neck cancer	2.02e-05	0.000627	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—NAT2—head and neck cancer	2e-05	0.000621	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.89e-05	0.000589	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—TYMS—head and neck cancer	1.86e-05	0.000578	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.84e-05	0.000572	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.81e-05	0.000563	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GPX1—head and neck cancer	1.76e-05	0.000547	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—DPYD—head and neck cancer	1.75e-05	0.000545	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.74e-05	0.000542	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—YAP1—head and neck cancer	1.66e-05	0.000517	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—TYMS—head and neck cancer	1.66e-05	0.000516	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.65e-05	0.000514	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.64e-05	0.00051	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GPX1—head and neck cancer	1.57e-05	0.000489	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.56e-05	0.000484	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—TYMS—head and neck cancer	1.51e-05	0.000471	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.5e-05	0.000465	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GPX1—head and neck cancer	1.43e-05	0.000446	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.43e-05	0.000445	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.42e-05	0.000441	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.28e-05	0.000397	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.2e-05	0.000373	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.16e-05	0.000362	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PTEN—head and neck cancer	1.05e-05	0.000325	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.04e-05	0.000322	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—TYMS—head and neck cancer	9.98e-06	0.00031	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTM1—head and neck cancer	9.86e-06	0.000307	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GPX1—head and neck cancer	9.45e-06	0.000294	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.35e-06	0.000291	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PTGS2—head and neck cancer	9.25e-06	0.000288	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PTEN—head and neck cancer	9.04e-06	0.000281	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PTGS2—head and neck cancer	8.43e-06	0.000262	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PTEN—head and neck cancer	8.06e-06	0.000251	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PIK3CA—head and neck cancer	7.37e-06	0.000229	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PTEN—head and neck cancer	7.35e-06	0.000229	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PIK3CA—head and neck cancer	6.37e-06	0.000198	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—AKT1—head and neck cancer	6.02e-06	0.000187	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PIK3CA—head and neck cancer	5.69e-06	0.000177	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.56e-06	0.000173	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—AKT1—head and neck cancer	5.21e-06	0.000162	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PIK3CA—head and neck cancer	5.19e-06	0.000161	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PTEN—head and neck cancer	4.85e-06	0.000151	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—AKT1—head and neck cancer	4.65e-06	0.000145	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—AKT1—head and neck cancer	4.24e-06	0.000132	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.42e-06	0.000106	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—AKT1—head and neck cancer	2.79e-06	8.69e-05	CbGpPWpGaD
